Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model

Proton boron capture therapy (PBCT) in a preclinical glioblastoma model exhibits increased therapeutic effectiveness with an increased cell death and mitophagy, supporting its use as a scalable strategy to treat glioblastoma.